Results 261 to 270 of about 204,414 (356)
Correction to 'Regulation of the androgen receptor by SET9-mediated methylation'. [PDF]
europepmc +1 more source
Phosphorylation-stabilized CRTC1 cooperates with CBP and androgen receptor to transactivate AMH expression and drive polycystic ovary syndrome. [PDF]
Ke Y+7 more
europepmc +1 more source
Abstract Patients with recurrent high‐grade glioma (rHGG) have a poor prognosis with median progression‐free survival (PFS) of <7 months. Responses to treatment are heterogenous, suggesting a clinical need for prognostic models. Bayesian data analysis can exploit individual patient follow‐up imaging studies to adaptively predict the risk of progression.
Daniel J. Glazar+5 more
wiley +1 more source
Androgen receptor overexpression by immunohistochemistry in malignant salivary gland tumors in Tanzania. [PDF]
Matiku S+8 more
europepmc +1 more source
Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors
S. KUPFER+3 more
openalex +2 more sources
Abstract Prostate cancer (PCa) is a multifaceted disease that envelops 1.41 million new cases globally. It is the second most common cancer reported in men. Its heterogeneity and indolent growth, coupled with incompetent early screening methods such as serum prostate‐specific antigen level estimations and digital rectal examinations, contribute to its ...
Anveshika Manoj+2 more
wiley +1 more source
Preclinical Evaluation of Bavdegalutamide (ARV-110), a Novel PROteolysis TArgeting Chimera Androgen Receptor Degrader. [PDF]
Snyder LB+13 more
europepmc +1 more source
Abstract Background Neuroendocrine carcinoma of the prostate is a rare tumor subtype found in the spectrum of prostate cancer, and is more difficult to detect, due to the low prostate‐specific antigen values associated with it. A high degree of suspicion is hence needed to arrive at the diagnosis in such cases.
Uttam Kumar Mete+3 more
wiley +1 more source